AST 002 - Astrogen
Alternative Names: AST-002 - AstrogenLatest Information Update: 28 Feb 2026
At a glance
- Originator Astrogen
- Class Vascular disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cerebrovascular disorders; Traumatic brain injuries
Most Recent Events
- 28 Feb 2026 No recent reports of development identified for preclinical development in Cerebrovascular-disorders in South Korea (Parenteral, Injection)
- 28 Feb 2026 No recent reports of development identified for preclinical development in Traumatic-brain-injuries in South Korea (Parenteral, Injection)
- 25 Jan 2022 Preclinical trials in Cerebrovascular disorders in South Korea (Parenteral) (Astrogen pipeline, January 2022)